chrisvoncsefalvay/vaers-outcomes huggingface dataset:
WORSENED OF PAIN AFTER GETTING THE VACCINE; This spontaneous report received from a consumer concerned multiple patients. The patient's height, and weight were not reported. The patient's past medical history included: chronic pain. The patient received covid-19 vaccine  (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced worsened of pain after getting the vaccine. The action taken with covid-19 vaccine  was not applicable. The outcome of worsened of pain after getting the vaccine was not reported. This report was non-serious.
Received vaccine approximately 15:00 hrs, developed nausea, vomiting, fever of 101F around 19:00 hrs. The next day she returned to see MD, temp. 102.7F, erythematous patch with central induration around vaccine site, intermitten chills, fatigue, nausea and vomiting. Blood cultures and labs drawn, peripheral IV started, anzement and unasyn given. MD discussed case with Dermatologist, pt. admitted to  Medical Center for further evaluation and treatment.  03/05/2007 MR received for a 3 day hospital stay for fever, nausea and vomiting, with inability to keep medications down which occured on the evening of her Pneumovax.    PE showed a 3 inch erythematous patch on LUE with central 2cm. induration.  Temp-102.7'F.  Otherwise WNL. Pt. treated with antibiotics and discharged on day 3. Principal DX: Arthus Reaction.  Secondary DXs: APF, HTN, GERD, Fibromyalgia, IBS.
had both shots and got shingles/Suspected Vaccination Failure; got the shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: had both shots and got shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: got the shingles).The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 08-MAR-2023 This case was reported by a patient via interactive digital media. The patient had both shingles shots and still got the shingles.  The reporter stated that it was horrible experience. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Severe dizziness, vertigo, fatigue, brain fog. Persistent since vaccination 9 days ago.
pt recv vax 17AUG95 & contracted chickenpox;this is second child in family to get chicken pox p/receiving vax in 1995;
Symptoms for 24 hours: Headache, slight fever (less than 100*), pain and inflammation around injection site, fatigue, feelings of weakness.   Symptoms which lasted for only 15-20 minutes precisely 24 hours after dosage: severe feelings of illness: dizziness, nausea, diarrhea, chills while sweating, fever, extreme fatigue and muscle weakness.
Elevated area, looks like a bug  bite; Red elevated area; Itchyelevated area; This case was reported by a consumer via call center representative and described the occurrence of swelling in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2022, the patient received the 2nd dose of Shingrix. In October 2022, less than a week after receiving Shingrix, the patient experienced swelling, erythema and pruritus. On an unknown date, the outcome of the swelling, erythema and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the swelling, erythema and pruritus to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-OCT-2022 Reporter's Comment: The reporter was the patient.  The patient received her Shingrix about 48 hours ago.  The patient was experiencing an itchy, red, and elevated area which she described looks like a bug bite.  The patient did not wish to provide DOB (date of birth). However, provided year of birth. The reporter consented to follow up.
Right hip pain morning two days following third pfizer covid vaccine. Only other side effct has been a sore deltoid on my left arm, the injection site. No treatment or doctors visit yet.
No adverse events until day 8 post vaccination. Woke up in the morning with a rash over my right deltoid where the vaccination was administered. It was itchy and painful, and developed into a 2-inch circumferential welt. This was present for approximately 36 hours and disappeared without treatment.
sick ever since; went from 100 lbs to 85 lbs; has brain fog; planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick ever since), LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046B21A) for COVID-19 vaccination.     Concomitant products included TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive). On an unknown date, the patient experienced ILLNESS (sick ever since), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog). The patient was treated with PREDNISONE at a dose of 30 milligram once a day; PREDNISONE at a dose of 20 milligram; PREDNISONE at a dose of 10 milligram and DOXYCYCLINE at a dose of 1 dosage form. At the time of the report, ILLNESS (sick ever since), LICHEN PLANOPILARIS (planopilaris on her scalp which started small,it has gotten progressively worse and not getting better,this one massive), WEIGHT DECREASED (went from 100 lbs to 85 lbs) and FEELING ABNORMAL (has brain fog) was resolving.            The concomitant medication includes- Anti-anxiety medication for unknown  indication.  The patient was on third round of doxycycline and prednisone. The skin and scalp were to clear up, the brain felt sharp again. The patient was working on gaining back the 15 lbs of weight lost.     Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: event outcome updated
Sore arm; Extreme fatigue; Extreme muscle weakness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 55 year-old female patient received bnt162b2 (BNT162B2), administration date 03Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single), for COVID-19 immunization; Covid-19 vaccine (Dose 2, single), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 04Nov2021, outcome "not recovered", described as "Sore arm"; FATIGUE (non-serious) with onset 04Nov2021, outcome "not recovered", described as "Extreme fatigue"; MUSCULAR WEAKNESS (non-serious) with onset 04Nov2021, outcome "not recovered", described as "Extreme muscle weakness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
230AM c/o arm aching & chills w/shaking & brief confusion of about 5min duration;felt warm to touch, but hands & arms cold, clammy;mom gave 2 APAP & was recv in about 1 1/2hr;Mom states MD states no more shots;
flu-like symptoms; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment was unknown.
Unresponsiveness, glazed over eyes, unable to focus, this Payo tint
Reports that she has an indention on her left deltoid area. She believes it was from when she received the influenza immunization.  She denies any muscular issues or ROM deficiencies. She just wants to document. The indention measures 1 X 1.5 cm. No discoloration or bruising noted to the area. Verified per clinic immunization received in left deltoid on 10/27.
Patient reported swelling at lips at 4:30 PM. Patient took Benadryl 50mg at that time. At 6:30 PM patient reported swelling going down. On 11-13-13 patient report all symptoms were gone.
Narrative: Patient received Moderna Covid #1 on 3/12/21. There are no further notes or scanned records to indicate what happened between this date and his recorded date of death of 4/19/21. No autopsy report available. There were 38 days from time of first vaccine to date of death.
got violently ill; sick for 3 weeks afterwards with flu symptoms; lose all of his muscular ability; Initial information received on 12-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case is linked to cases 2022SA422349(CLUSTER) and 2022SA425046(CLUSTER).  This case involves a 78 years old male patient who got violently ill, lose all of his muscular ability and sick for 3 weeks afterwards with flu symptoms after receiving vaccine INFLUENZA VACCINE.     The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, lot number and expiry date was unknown) via unknown route in unknown administration site for Immunization.  On an unknown date the patient developed a non-serious event of got violently ill (illness) and sick for 3 weeks afterwards with flu symptoms (influenza) (latency: unknown) following the administration of INFLUENZA VACCINE.  On 15-OCT-2021 the patient developed a non-serious event of lose all of his muscular ability (muscle discomfort) (latency: unknown) following the administration of INFLUENZA VACCINE.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the events.   Outcome: Recovered / Resolved on an unknown date for all events.
loss of appetite; diarrhea; hurting; can hardly walk/weak; can hardly walk/weak; fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PAIN (hurting), GAIT DISTURBANCE (can hardly walk/weak) and ASTHENIA (can hardly walk/weak) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PAIN (hurting), GAIT DISTURBANCE (can hardly walk/weak), ASTHENIA (can hardly walk/weak) and PYREXIA (fever). The patient was treated with PREDNISONE in March 2021 at an unspecified dose and frequency. On 17-Mar-2021, PAIN (hurting) and PYREXIA (fever) had resolved. At the time of the report, DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), GAIT DISTURBANCE (can hardly walk/weak) and ASTHENIA (can hardly walk/weak) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
The patient presented to the vaccination site on 12/05/21. The client notified RN that she received a single dose of (Cansino) COVID vaccine in (Privacy) on (4/28/21). RN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Pfizer first dose. Per CDC guidance, approval to proceed with COVID vaccine Pfizer first dose was obtained from medical consult team, Vaccine Operations Lead, RN via text message. Client received COVID vaccine Pfizer Lot# FF8841 on 12/05/2021. The client did not report any symptoms during the observation period. The client left the vaccination site at 1448.
Mom reported to clinic child taken to ER @ 3A last night p/fever reached 105. Treated for fever in ER; no infection was dx @ this time. Mom has return appt for 17JAN91 for f/u.
mom heard gurgling sound & found pt feet, hands & whole body jerking x30sec;pt exp edema @ inj site & fussy, pt eye matted shut and staring;
was uncomfortable for the patient; This non-serious case was reported by a consumer via call center representative and described the occurrence of discomfort in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 05-JUN-2023, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced discomfort (Verbatim: was uncomfortable for the patient).  The outcome of the discomfort was not reported.   It was unknown if the reporter considered the discomfort to be related to Shingrix.     It was unknown if the company considered the discomfort to be related to Shingrix.   Linked case(s) involving the same patient:  US2023135770   Additional Information: GSK Receipt Date: 03-OCT-2023 Reporter was the daughter calling on behalf of her father who was a male patient that received Shingrix vaccine. The reporter informed about Shingrix vaccine and went ahead and told this agent about various adverse events. The reporter stated that the 1st dose of Shingrix was received 5-JUN-2023 and it was uncomfortable for the patient. Reporter had no information about lot, expiry, location of administration, route of administration to provide. No information was provided about this dose. The 2nd vaccine was given on 22-AUG-2023 and 3rd one was on 31-AUG-2023. These vaccinations were given at 3 different pharmacies and there was only one pharmacy that was known. The reporter did not consent to follow up. The consent to follow up with healthcare professional was declined per a phone. The reporter was advised to contact his healthcare professional for further instructions. For the tolerance of later dose, refer case - US2023135770.; Sender's Comments:  US-GSK-US2023135770:3rd dose, same reporter
refrigeration excursions identified; No Adverse Event; vaccines undergone several temperature excursions and was administered to the patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (refrigeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (vaccines undergone several temperature excursions and was administered to the patient) and NO ADVERSE EVENT (No Adverse Event) in a 40-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2022 at 4:46 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 22-Sep-2022 at 4:46 PM,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (vaccines undergone several temperature excursions and was administered to the patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (refrigeration excursions identified) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (refrigeration excursions identified), POOR QUALITY PRODUCT ADMINISTERED (vaccines undergone several temperature excursions and was administered to the patient) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (refrigeration excursions identified) and POOR QUALITY PRODUCT ADMINISTERED (vaccines undergone several temperature excursions and was administered to the patient).    No concomitant medications were reported.  Vaccination site was deltoid muscle.  On 07-Sep-2022, the vials were initially moved from freezer to refrigerator.  The nurse reported that, Moderna Monovalent and Bivalent vaccines stored in the refrigerator that underwent several temperature excursions going back in Aug-2022. It was reported that, refrigeration excursions were identified, and state vaccines were housed in these units. The manufactures were notified, and the state department made aware of the situation. The storage condition of vial at the time of excursion was in refrigerator. The vials were not visually inspected.  No adverse reactions reported for the patient.  No treatment medications were reported.
Injection given in very forceful manner, felt like it hit bone and gave me an "electrical" jolt. I was in shock for a few hours. Sensations progressed for the next few days from pain, soreness & aching extending from the top part of my arm down my arm to numbness and tingling in my last 3 fingers on my left hand. Within a month it progressed to more severe symptoms of the same and then pain & aching branching down my left shoulder blade.These symptoms have continued to date and are very uncomfortable. The symptoms are not alleviated by ibuprofen. The injection site continues to be tender.
Rash developed very soon after administration on Influenza vac. Rash at the site on vaccine adm.
Very sore/limp arm at day of shot and pretty sore the next day as well. 5 days after shot red blouchy circle started to appear at sight. Exactly one week later it is a very obvious blochy red spot
Various post vaccine symptoms of C-pox isolation, Sx: fever, headache. Lesions, 2 with crusty scabs.
This is a spontaneous report recieved from a contactable consumer (patient) from Pfizer sponsored program. A female patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/ lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient also received desvenlafaxine succinate (PRISTIQ), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patients medical history included PTSD. The concomitant medications were not reported. On an unspecified date the patient experienced congestion. The patient reported that she had PTSD after my husband passed away and its not a good feeling and the one she was one she took off of it. Patient explained how prescription is at pharmacy now does not have funds to pick it up so she does not have medication. The outcome of the event was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
"Covid Arm" - on the arm with the injection, a large red splotch  3" x 8" , hot, itchy, lasted at least 12 days. Treated with Benadryl Gel with moderate results.
Intense chills for approximately 30 minutes; body aches, much like flu; headache and nausea.   Advil eases body aches, rest helped. By early afternoon, I was much better.
Vaccine given at 3 PM. 2 hrs later she developed chest constriction / SOB / myalgias / cough and bilateral conjunctivitis. Went to ED. Chest X-ray -> NL. Symptoms resolved with MOTRIN.
Starting 3 hrs /p DPT vaccine, rt leg warm & swollen. Crying & moaning for next several hrs. T-102 F. No high pitched screaming. Pt taken to ER on 28Jun90 was observed, given Tylenol /w Codeine,& D/C from ER.
chest heaviness, slight hives noted to face, states she "feels funny". She was given 25mg of Benadryl po and sent to emergency dept where she was given prednisone, pepcid and benadryl. She said the symptoms subsided slightly but after 24 hours she still is "feeling funny".
Swelling of left elbow and approx 5 inches below elbow and 6 inches above elbow.
I tested positive for COVID-19 on Jan 2, 2021. I had high fever for three days. For about 7 days I had muscle aches, burning sinuses and terrible headaches. My smell and taste were gone but slowly came back Feb. 2021. Brain fog lifted mostly in March. I got my 2nd Moderna vaccine April 10, 2021. Ten days after the second vaccine the parosmia started. I had a taste of rotten meat and motor oil constantly in my mouth. As of today Nov, 22, 2021, anything that has a scent is either gone or smells like rotten garbage. My taste is back about 80%. This past week I've picked up a few scents but they faded in seconds. I want to get a booster shot, but I don't want the parosmia to come back fully.
low grade fever followed by 4cm tender induration w/hives;also has faint blanching 1 to 2mm lesion body approx 15, non confluent;induration of DTAp site;fever;induration & erythema 7 hives;
I had a deep cough that caused me to lose my voice, it would be so bad that I could not even walk across the room. This lasted for three weeks. I was unable to even get out of bed to do my normal activities. Once I got into my doctor into my doctor, she said it was too late to test for COVID-19, RSV, Influenza. I was given a prescription for an inhaler and was told that my COPD had come back.